Absci (ABSI) Treasury Shares (2020 - 2026)
Absci's (ABSI) quarterly Treasury Shares came in at $5.0 million in Q1 2026, up 14.36% year-on-year from $4.4 million in Q1 2025, and up 32.32% quarter-over-quarter from $3.8 million in Q4 2025.
Absci (ABSI) Treasury Shares (2020 - 2026) Analysis & Trends
Absci has disclosed Treasury Shares across 7 years of filings, most recently posting $5.0 million for Q1 2026.
- Treasury Shares for Q1 2026 came in at $5.0 million, up 14.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 million (up 14.36% YoY), and the FY2025 annual result was $3.8 million, up 2.1% from the prior year.
- Treasury Shares came in at $5.0 million for Q1 2026 at Absci, up from $3.8 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $5.0 million in Q1 2026 to a low of $37886.0 in Q2 2024.
- The 5-year median for Treasury Shares is $1.0 million (2022), against an average of $1.9 million.
- Across the five-year window, Treasury Shares tumbled 93.59% in 2024 and soared 11521.71% in 2025, its largest moves.
- Absci's Treasury Shares stood at $1.0 million in 2022, then surged by 116.95% to $2.2 million in 2023, then jumped by 68.84% to $3.7 million in 2024, then advanced by 2.1% to $3.8 million in 2025, then surged by 32.32% to $5.0 million in 2026.
- The last three Treasury Shares figures came in at $5.0 million (Q1 2026), $3.8 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 5.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.01 Mn |
| Mar 31, 2026 | 5.01 Mn |
| Dec 31, 2025 | 3.79 Mn |
| Dec 31, 2025 | 3.79 Mn |
| Sep 30, 2025 | 4.42 Mn |
| Sep 30, 2025 | 4.42 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 4.38 Mn |
| Mar 31, 2025 | 4.38 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 99,186.00 |
| Sep 30, 2024 | 99,186.00 |
| Jun 30, 2024 | 37,886.00 |
| Jun 30, 2024 | 37,886.00 |
| Mar 31, 2024 | 394,736.00 |
| Mar 31, 2024 | 394,736.00 |
| Dec 31, 2023 | 2.20 Mn |
| Dec 31, 2023 | 2.20 Mn |